CVRx sued over sales claims as stock plunges 60%
Alpha Vantage · Pluang · · AI-summarised by FinFlash
Berman Tabacco filed a class action against CVRx and its officers, alleging they misled investors about revenue growth, sales practices and regulatory compliance. The suit follows CVRx's disclosure of a DOJ investigation into improper marketing and kickbacks tied to its Barostim device, plus a cut to its 2026 revenue forecast. Shares fell 60%.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.